Erasca hits ‘home run’ with cancer data as analyst suggests stock drop prompted by patient death
Erasca hits ‘home run’ with cancer data as analyst suggests stock drop prompted by patient death
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.
Erasca hits ‘home run’ with cancer data as analyst suggests stock drop prompted by patient death
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.